Literature DB >> 9102204

Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane.

M Takahashi1, K Fukuda, T Ohata, T Sugimura, K Wakabayashi.   

Abstract

Nitric oxide (NO) is an important bioregulatory mediator involved in a variety of biological processes under both physiological and pathological conditions. To assess whether NO production is altered in colon carcinogenesis, the expression levels and localization of two isoforms of NO synthase, inducible NO synthase (iNOS) and endothelial constitutive NO synthase (eNOS), were examined by immunoblot and immunohistochemical methods in normal colonic mucosa and colon carcinomas induced by azoxymethane in male F344 rats. All colon carcinoma tissues examined were found to have an increased expression of iNOS and eNOS proteins as compared to normal colonic mucosa. In particular, the pronounced staining of iNOS protein localized to the luminal surface of carcinoma epithelial cells was not detectable in normal colon epithelium. The neovasculature in tumor tissues also demonstrated intense eNOS immunoreactivity in endothelial cells. These findings indicate that NO production is markedly elevated in azoxymethane-induced rat colon carcinomas, suggesting that regulatory pathways involving this mediator have some biological relevance to colon carcinogenesis in this model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9102204

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

2.  Luminal 5-HT stimulates colonic bicarbonate secretion in rats.

Authors:  I Kaji; Y Akiba; H Said; K Narimatsu; J D Kaunitz
Journal:  Br J Pharmacol       Date:  2015-08-26       Impact factor: 8.739

3.  Types and amount of dietary fat and colon cancer risk: Prevention by omega-3 fatty acid-rich diets.

Authors:  Bandaru S Reddy
Journal:  Environ Health Prev Med       Date:  2002-07       Impact factor: 3.674

4.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux.

Authors:  Jong Dae Bae; Ki Hoon Jung; Woo Sup Ahn; Sung Han Bae; Tae Jung Jang
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

6.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

7.  Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis.

Authors:  Hemant K Roy; Ramesh K Wali; Young Kim; Yang Liu; John Hart; Dhananjay P Kunte; Jennifer L Koetsier; Michael J Goldberg; Vadim Backman
Journal:  FEBS Lett       Date:  2007-07-16       Impact factor: 4.124

8.  ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.

Authors:  Jason J Luke; Patricia LoRusso; Geoffrey I Shapiro; Andrew Krivoshik; Robin Schuster; Takao Yamazaki; Yukinori Arai; Allam Fakhoury; Carl Dmuchowski; Jeffrey R Infante
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-25       Impact factor: 3.333

Review 9.  iNOS-selective inhibitors for cancer prevention: promise and progress.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  Future Med Chem       Date:  2012-11       Impact factor: 3.808

10.  Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling.

Authors:  Suresh Guruswamy; Chinthalapally V Rao
Journal:  Gene Regul Syst Bio       Date:  2008-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.